DDG-39
DDG-39 is a cytosine nucleoside analogue demonstrating potent and selective antiviral activity against HIV-1 and HBV in vitro, with an average IC50 of 0.61 μM. It serves as a research tool for investigating antiviral mechanisms and nucleoside analogue therapies in cell-based assays.
Product Specifications
CAS Number
119555-47-4
Product Name Alternative
HIVProtease, HIV Protease, HIV-1, HBV, DDG39, DDG-39, DDG 39, 1- (2,3-dideoxy-2-fluoropentofuranosyl) cytosine, Antiviral
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Protein Biochemistry
Purity
99.17% (May vary between batches)
Smiles
F[C@@H]1[C@@H] (O[C@H] (CO) C1) N2C (=O) N=C (N) C=C2
Molecular Formula
C9H12FN3O3
Molecular Weight
229.21
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036122-ML750 100 µL
GNA11, NT (GNA11, GA11, Guanine nucleotide-binding protein subunit alpha-11, Guanine nucleotide-binding protein G (y) subunit alpha) (MaxLight 750) discontinued
Sign In for Pricing
View Details 130875-HRP 100 µL
PARD3B (Partitioning Defective 3 Homolog B, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 19 Protein, PAR3-beta, Partitioning Defective 3-like Protein, PAR3-L Protein, ALS2CR19, PAR3B, PAR3L, MGC16131) (HRP)
Sign In for Pricing
View Details